Compounds > ampelopsin
Page last updated: 2024-09-04

ampelopsin and Liver Neoplasms

ampelopsin has been researched along with Liver Neoplasms in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's9 (69.23)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Jing, T; Li, H; Lu, J; Song, X; Xin, Q; Yuan, M1
Kou, X; Lv, J; Qi, S; Qi, Z; Yan, L1
Liu, DY; Luo, GQ; Zeng, S1
Ai, QD; Gu, J; He, P; Qin, L; Shi, YN; Wang, W; Zhang, S; Zhou, XD1
Dai, W; Jiang, L; Li, M; Li, Z; Yang, Y; Ye, WC1
Bi, Y; Chen, J; Fu, J; Liu, B; Wang, X; Xia, T; Zhu, R1
Chen, S; Han, L; Liao, Q; Xu, Y; Yao, A; Zhang, H; Zhang, X; Zhang, Z; Zou, Z1
Duan, J; He, YF; He, YH; Li, MY; Liang, YR; Lu, CJ; Xiang, LJ; Yuan, WZ; Zhang, J1
Hu, M; Huang, H; Li, M; Li, P; Zhao, R1
Cao, Y; Chen, N; Chen, X; Li, M; Liu, B; Liu, J; Lu, C; Xia, J; Zhang, C; Zhang, Q; Zhu, R1
Li, MY; Li, R; Liu, B; Liu, J; Liu, ZK; Miao, HL; Qiu, ZD; Shu, Y; Wang, DJ; Zeng, GF; Zhang, QY; Zhu, RZ1
Bao, S; Chen, N; Chen, X; Chen, Y; Li, M; Liu, B; Liu, J; Xu, F; Zhang, Q; Zhou, W; Zhu, R1
Jiang, L; Li, M; Liang, J; Liu, B; Liu, J; Lu, C; Ma, S; Ren, H; Zhang, Q; Zhu, R1

Reviews

1 review(s) available for ampelopsin and Liver Neoplasms

ArticleYear
Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 142

    Topics: Carcinoma, Hepatocellular; Flavonols; Humans; Liver Diseases; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Regeneration; Non-alcoholic Fatty Liver Disease; Protective Agents

2021

Other Studies

12 other study(ies) available for ampelopsin and Liver Neoplasms

ArticleYear
In vitro efficacy of ampelopsin against Echinococcus granulosus and Echinococcus multilocularis.
    The Journal of veterinary medical science, 2019, Dec-26, Volume: 81, Issue:12

    Topics: Animals; Anticestodal Agents; Carcinoma, Hepatocellular; Cells, Cultured; Echinococcosis; Echinococcus granulosus; Echinococcus multilocularis; Flavonoids; Hepatocytes; Humans; Liver Neoplasms

2019
Ampelopsin induces apoptosis in HepG2 human hepatoma cell line through extrinsic and intrinsic pathways: Involvement of P38 and ERK.
    Environmental toxicology and pharmacology, 2015, Volume: 40, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Flavonoids; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; MAP Kinase Signaling System; Nitric Oxide Synthase Type II; Phosphorylation

2015
[Inhibitory effects of ampelopsin on angiogenesis].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2006, Volume: 29, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cattle; Cell Line, Tumor; Cell Proliferation; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Flavonoids; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Plants, Medicinal; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2006
Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation.
    Pharmaceutical biology, 2023, Volume: 61, Issue:1

    Topics: Carcinoma, Hepatocellular; ErbB Receptors; Humans; Liver Neoplasms; Network Pharmacology

2023
Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.
    BMC complementary medicine and therapies, 2021, Jul-06, Volume: 21, Issue:1

    Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Flavonols; Humans; In Vitro Techniques; Liver Neoplasms; Mice; Mice, Nude; Random Allocation

2021
Dihydromyricetin induces mitochondria-mediated apoptosis in HepG2 cells through down-regulation of the Akt/Bad pathway.
    Nutrition research (New York, N.Y.), 2017, Volume: 38

    Topics: Ampelopsis; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Caspase 3; Down-Regulation; Flavonols; Hep G2 Cells; Humans; Liver Neoplasms; Mitochondria; Phosphorylation; Plant Extracts; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Signal Transduction

2017
Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.
    World journal of gastroenterology, 2017, Sep-14, Volume: 23, Issue:34

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Proliferation; Disease Progression; Down-Regulation; Flavonols; Flow Cytometry; Hep G2 Cells; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptor, Notch1; RNA Interference; RNA, Small Interfering; Signal Transduction; Up-Regulation

2017
Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
    Oncology reports, 2013, Volume: 30, Issue:5

    Topics: Carcinoma, Hepatocellular; cdc25 Phosphatases; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; Flavonols; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Protein Kinases; Signal Transduction

2013
Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism.
    Scientific reports, 2014, Apr-10, Volume: 4

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cisplatin; Enzyme Activation; Flavonols; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; RNA Interference; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2014
Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
    World journal of gastroenterology, 2014, Aug-07, Volume: 20, Issue:29

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Flavonols; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphorylation; Protein Kinase C-delta; Signal Transduction; Time Factors

2014
Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
    Molecular medicine reports, 2015, Volume: 11, Issue:3

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Flavonols; Liver Neoplasms; Mice; Models, Biological; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta

2015
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Flavonols; Humans; Liver Neoplasms; Organoplatinum Compounds; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53

2015